Fisher et al., J. Cereb. Blood Flow Metab. 15(6), 953-9, 1995.* |
Lyons et al., Brain Res., 558(2), 315-20, 1991.* |
Masuda, T., Kagoshima Daigaku Igaku Zasshi, 46(2), 67-76, 1994.* |
Yamada et al., J. Cereb. Blood Flow Metab., 11(3), 472-8, 1991.* |
Burgess et al., “The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins”, Annual Rev. Biochem., 58:575-606 (1989). |
Fisher et al., “Delayed Treatment with Intraveneous Basic Fibroblast Growth Factor Reduces Infarct . . . . ”, Journal of Cerebral Blood Flow and Metabolism, 15:953-959 (1995). |
Florkiewicz et al., “Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons”, Proc. Natl. Acad. Sci., 86:3978-3981 (1989). |
Gotti et al., “The pharmacotherapy of focal cortical ischaemia in the mouse”, Brain Research, 522:290-307 (1990). |
Jiang et al., “Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces . . . ”, Journal of the Neurological Sciences, 139:173-179 (1996). |
Kawamata et al., “Intracisternal Basic Fibroblast Growth Factor (bFGF), Enhances Behavioral . . . . ”, Journal of Cerebral Blood Flow and Metabolism, 16:542-547 (1996). |
Morrison et al., “Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture”, Proc. Natl. Acad. Sci., 83:7537-7541 (1986). |
Rosenberg et al., “Excitotoxic Neuronal Disease: Future Therapies for Epilepsy, Stroke . . . , ” Continum, Lifelong learning in neurology, 2:92-112 (1996). |
Skene et al., “Axonal Growth-Associated Proteins”, Am. Rev. Neurosci., 12:127-56 (1989). |
Tanaka et al., “Basic Fibroblast Growth Factor Increases Regional Cerebral Blood Flow and Reduces . . . ”, Stroke, 26(11) (1995). |
Thomas, “Fibroblast growth factors”, The FASEB Journal, 1:434-440 (1987). |
Yamada et al., “Basic Fibroblast Growth Factor Prevents Thalamic Degeneration After Cortical . . . . ”, Journal of Cerebral Blood Flow and Metabolism, 11:472-478 (1991). |
Finklestein et al., Stroke 21-III-124, 1990. |